Basic Adalat Information

• INN (International Nonproprietary Name): Nifedipine.
• Brand Names Available In Canada (English): Adalat, Adalat CC, Procardia XL, Nifediac, Nifedical, Afeditab CR; generics may be supplied by Teva, Sandoz/Novartis, Mylan, Actavis, Apotex and others as locally available.
• ATC Code: C08CA05 — C08: Calcium Channel Blockers; C08CA: Dihydropyridine Derivatives; C08CA05: Nifedipine.
• Drug Class: Dihydropyridine Calcium Channel Blocker indicated for hypertension and angina pectoris, including several angina subtypes.
• Forms & Dosages Sold: Extended‑release tablets 30 mg, 60 mg, 90 mg; Immediate‑release capsules 10 mg, 20 mg (less common); Modified‑release tablets 20 mg, 30 mg, 60 mg.
• Standard Dosages: Hypertension start 30 mg ER once daily; maintenance 60–90 mg QD; max commonly 90 mg ER. Chronic stable angina similar ER dosing. Pediatric specialist dosing 0.25–0.5 mg/kg/day where used.
• Dosage Adjustments: Reduce in hepatic impairment; cautious titration in elderly; no routine renal adjustment but monitor clinically.
• Missed Dose / Overdose: If a dose is missed, take when remembered unless close to next dose; do not double up. Overdose may cause profound hypotension and requires urgent medical attention with supportive care.
• Storage: Store at 20–25°C, protect from light and moisture and keep in original packaging.
• Classification: Prescription‑only medicine (Rx) in most jurisdictions.
• Absolute Contraindications: Known hypersensitivity to nifedipine or excipients; severe coronary artery disease; recent (≤2 weeks) myocardial infarction; cardiogenic shock; severe aortic stenosis; concurrent rifampin use reduces efficacy.
• Common Side Effects: Headache, flushing, peripheral oedema, dizziness on standing, fatigue, nausea.

Latest Research Highlights

Patients ask whether newer trials have shown nifedipine ER is better than other long‑acting CCBs for systolic blood pressure control.

High‑quality randomized evidence directly comparing nifedipine ER and amlodipine in Canada is limited in the 2022–2025 window.

Observational registry data internationally continue to report peripheral oedema as a frequent reason for switching dihydropyridine therapy and for affecting adherence with once‑daily ER formulations.

Meta‑analyses of dihydropyridine calcium channel blockers support stroke prevention benefits in older adults, though trials differ by agent and population.

Mechanistic pharmacology work reiterates that nifedipine produces arterial vasodilation with less negative inotropy than non‑dihydropyridines, and that reflex heart‑rate effects vary by formulation and dose.

• Research Takeaway: Direct Canada‑specific RCT data comparing nifedipine ER to amlodipine during 2022–2025 are limited.
• Research Takeaway: Observational and meta‑analytic work supports class benefits but highlights peripheral oedema as an adherence driver.
• Research Takeaway: More long‑term, Canada‑focused outcome studies are needed, with better rural and Indigenous representation.

Clinical Effectiveness In Canada

Are clinicians in Canada still comfortable using nifedipine for blood pressure and angina?

Health Canada maintains product monographs and regulatory monographs that clinicians consult for safety and indications.

Nifedipine is an established prescription calcium‑channel blocker that reliably lowers systolic blood pressure when given as an ER formulation in 30–90 mg ranges.

ER dosing provides once‑daily control and is commonly used for chronic stable angina symptom control as well.

Provincial formulary listings vary: some provinces include generic nifedipine on core formularies, while others may require special authorization or step therapy for certain age groups or indications.

Pharmacists should display the DIN on product pages and prescriptions and use Health Canada’s database to retrieve exact DINs for the brand or generic supplied.

Monograph Versus Product Monograph Versus DIN:

• Monograph: General drug class information and accepted uses.
• Product Monograph: Manufacturer‑specific indications, dosing, and safety.
• DIN: Drug Identification Number used to track the specific product in Canada.

For patients on public plans, prescribers should document indication and prior therapy to satisfy reimbursement requirements.

Pharmacists can suggest cost‑effective generics at Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs when coverage or price is a concern.

Indications And Expanded Uses

What is nifedipine approved for, and when might specialists use it off‑label?

Approved indications include hypertension and angina pectoris, including vasospastic or variant angina, with ER dosing typically started at 30 mg once daily and titrated up to 90 mg as needed.

Off‑label uses seen in specialty Canadian practice include pediatric hypertension under specialist supervision (0.25–0.5 mg/kg/day), some transplant‑associated hypertension cases, select Raynaud’s phenomenon cases, and historical use in preterm labour (not routine).

• When prescribing off‑label: document clinical rationale, obtain informed consent, and outline a monitoring plan including BP and adverse‑effect checks.
• Use bilingual consent materials and telemedicine for remote or Indigenous communities when needed.

Composition And Brand Landscape

Which branded and generic nifedipine products might patients find in Canada?

Common branded forms internationally include Adalat and Adalat CC, Procardia XL, Nifediac, Nifedical and Afeditab CR.

Extended‑release tablets commonly come in 30, 60 and 90 mg strengths; immediate‑release forms of 10 and 20 mg exist but are less commonly used in outpatient management.

• Packaging norms: 28 or 30‑tablet blister packs are common.
• Storage: store at 20–25°C and keep in original package.
• When buying online, confirm the DIN and Health Canada licensing for any Canadian e‑pharmacy.

Contraindications And Special Precautions

Who should not take nifedipine, and which patients need closer monitoring?

Absolute contraindications include known hypersensitivity to nifedipine or excipients, severe coronary artery disease, recent myocardial infarction within two weeks, cardiogenic shock, severe aortic stenosis, and concurrent rifampin use which reduces nifedipine efficacy.

Relative precautions include impaired hepatic function, severe hypotension, congestive heart failure, diabetes, hypothyroidism and advanced age.

Community and cultural context: higher cardiovascular comorbidity in some Indigenous and remote populations calls for careful titration and shared care with local primary care and nursing stations.

Pharmacy workflow: flag interactions and contraindications in provincial e‑health records and recommend baseline BP and heart‑rate monitoring.

Dosage Guidelines

How is nifedipine dosed in routine Canadian practice?

Start hypertension treatment with 30 mg ER once daily and reassess in 1–2 weeks.

Maintenance doses commonly range from 60–90 mg once daily with a typical maximum of 90 mg ER.

For chronic stable angina, dosing mirrors hypertension dosing for ER formulations; immediate‑release forms are occasionally used for acute symptom relief but are less suitable for outpatient rapid BP lowering.

• Start low and increase by ~30 mg increments when needed; reassess BP and heart rate after 1–2 weeks.
• Adjust downward for hepatic impairment and consider low starting doses in elderly patients.

Patient advice: take ER tablets as a whole, do not crush, and follow bilingual medication instructions provided with the product.

Interactions Overview

Which drugs and foods interact with nifedipine?

Major interactions involve potent CYP3A4 inducers such as rifampin that reduce nifedipine levels and efficacy.

CYP3A4 inhibitors including some azole antifungals and certain macrolide antibiotics can raise nifedipine concentrations and increase hypotension risk.

Grapefruit and grapefruit juice increase nifedipine exposure and should be avoided or kept consistent.

• Pharmacists should prioritise checking provincial drug interaction alerts and counsel on grapefruit avoidance.
• Flag over‑the‑counter supplements like St. John’s wort in e‑health medication lists since they induce CYP3A4.

Cultural Perceptions And Patient Habits

What do Canadian patients say about Adalat and nifedipine?

Canadians value universal coverage and clear pricing, and many prefer generics that are covered on provincial formularies.

Patients often discuss peripheral oedema and flushing in online forums as reasons to switch to alternative agents.

Rural patients report issues with refill timing and limited stock at smaller pharmacies, while Indigenous and remote communities favour culturally safe counselling, nurse‑led monitoring and telehealth.

• Pharmacies should use plain‑language bilingual leaflets and offer medication reviews at major chains and community pharmacies.
• Offer blister packing and aligned refills for patients who travel or live remotely.

Availability And Pricing Patterns

Where to find nifedipine ER in Canada and what costs can patients expect?

Major chains stock nifedipine ER and generics through manufacturers like Apotex and Sandoz, while online Canadian pharmacies list products with DINs that should be verified against Health Canada.

Provincial formularies may subsidize generic nifedipine for eligible patients; uninsured patients will face retail pricing that varies by pharmacy and region.

Purchasing tip: confirm the DIN and Health Canada licensing when buying from any online e‑pharmacy.

In our online pharmacy, adalat is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Small pharmacies and rural suppliers can be affected by manufacturer backorders; pharmacists should keep therapeutic alternatives ready.

Comparable Medicines And Preferences

How does nifedipine compare with other dihydropyridines on Canadian formularies?

Common alternatives include amlodipine (Norvasc), felodipine and nicardipine.

Amlodipine has a longer half‑life and often provides once‑daily control with potentially less reflex tachycardia for some patients.

Clinical decisions should consider age, heart‑failure status, and public‑plan coverage.

Pharmacists should counsel on switching steps and safe tapering procedures.

FAQ

Is Adalat (nifedipine) covered by provincial drug plans?

Coverage varies by province and patient eligibility; generics are commonly listed but check ODB, PharmaCare or RAMQ and consult the pharmacist for DIN‑based alternatives.

Can I take nifedipine with other blood pressure medicines?

Often yes, but there is a risk of additive hypotension; pharmacists will check interactions and recommend monitoring.

Is grapefruit safe while taking nifedipine?

Grapefruit can increase nifedipine levels; avoidance or consistent intake is advised and patients should consult their prescriber or pharmacist.

What if I live in a rural or remote community?

Use your local nursing station or telehealth for monitoring, and ask the community pharmacist about blister packs and synchronized refills to avoid running out.

• Quick action steps: confirm DIN, bring a full medication list, report side effects such as leg swelling, and request bilingual information if needed.

Guidelines For Proper Use

How should pharmacists support safe nifedipine use in the community?

Counsel patients to swallow ER tablets whole and never crush them.

Storage should be at 20–25°C and in the original container.

Missed‑dose advice: take when remembered unless close to the next dose; do not double up.

Overdose may cause severe hypotension and requires urgent medical attention with cardiac monitoring.

Emphasise that stopping nifedipine suddenly can worsen angina or hypertension and tapering under guidance is recommended.

Monitoring Checklist:

• Baseline and periodic blood pressure and heart‑rate checks.
• Liver function tests when hepatic impairment is suspected.
• Assess for peripheral oedema and orthostatic symptoms.

Pharmacist Workflow:

• Check DIN and formulary coverage before dispensing.
• Screen for rifampin and CYP3A4 interacting drugs.
• Provide bilingual leaflets and offer blister packaging for remote or elderly patients.
• Include indication and prior therapy details in special authorization requests for public plans.

Delivery Across Canada (English)